Dr Mark White

  • Clinical Lecturer (Clinical Research Garscube)

Research interests

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2022 | 2021 | 2015
Number of items: 6.

2025

Cammareri, P. et al. (2025) Loss of colonic fidelity enables multilineage plasticity and metastasis. Nature, (doi: 10.1038/s41586-025-09125-5) (PMID:40468074) (Early Online Publication)

2024

Fetit, R. et al. (2024) Characterising neutrophil subtypes in cancer using scRNA sequencing demonstrates the importance of IL-1β/CXCR2 axis in generation of metastasis specific neutrophils. Cancer Research Communications, 4(2), pp. 588-606. (doi: 10.1158/2767-9764.CRC-23-0319) (PMID:38358352) (PMCID:PMC10903300)

2022

Corry, S. M. et al. (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71(12), pp. 2502-2517. (doi: 10.1136/gutjnl-2021-326183) (PMID:35477539) (PMCID:PMC9664095)

2021

Nicoll, Ruairidh, White, Mark, Loureiro Harrison, Luis, Cordiner, Ruth L.M., Daniel, Malcolm, Choo-Kang, Brian and Boyle, James G. (2021) Improving the quality of weekend medical handover on non-receiving medical hospital wards. BMJ Open Quality, 10(4), e000991. (doi: 10.1136/bmjoq-2020-000991)

Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).

2015

Watt, David, Roxburgh, Campbell ORCID logoORCID: https://orcid.org/0000-0002-2649-6695, White, Mark, Chan, Juen, Horgan, Paul ORCID logoORCID: https://orcid.org/0000-0001-5557-7905 and McMillan, Donald ORCID logoORCID: https://orcid.org/0000-0003-4260-5334 (2015) A survey of attitudes towards the clinical application of systemic inflammation based prognostic scores in cancer. Mediators of Inflammation, 2015, 842070. (doi: 10.1155/2015/842070) (PMID:26504363) (PMCID:PMC4609481)

This list was generated on Wed Jul 2 08:57:23 2025 BST.
Number of items: 6.

Articles

Cammareri, P. et al. (2025) Loss of colonic fidelity enables multilineage plasticity and metastasis. Nature, (doi: 10.1038/s41586-025-09125-5) (PMID:40468074) (Early Online Publication)

Fetit, R. et al. (2024) Characterising neutrophil subtypes in cancer using scRNA sequencing demonstrates the importance of IL-1β/CXCR2 axis in generation of metastasis specific neutrophils. Cancer Research Communications, 4(2), pp. 588-606. (doi: 10.1158/2767-9764.CRC-23-0319) (PMID:38358352) (PMCID:PMC10903300)

Corry, S. M. et al. (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71(12), pp. 2502-2517. (doi: 10.1136/gutjnl-2021-326183) (PMID:35477539) (PMCID:PMC9664095)

Nicoll, Ruairidh, White, Mark, Loureiro Harrison, Luis, Cordiner, Ruth L.M., Daniel, Malcolm, Choo-Kang, Brian and Boyle, James G. (2021) Improving the quality of weekend medical handover on non-receiving medical hospital wards. BMJ Open Quality, 10(4), e000991. (doi: 10.1136/bmjoq-2020-000991)

Watt, David, Roxburgh, Campbell ORCID logoORCID: https://orcid.org/0000-0002-2649-6695, White, Mark, Chan, Juen, Horgan, Paul ORCID logoORCID: https://orcid.org/0000-0001-5557-7905 and McMillan, Donald ORCID logoORCID: https://orcid.org/0000-0003-4260-5334 (2015) A survey of attitudes towards the clinical application of systemic inflammation based prognostic scores in cancer. Mediators of Inflammation, 2015, 842070. (doi: 10.1155/2015/842070) (PMID:26504363) (PMCID:PMC4609481)

Research Reports or Papers

Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).

This list was generated on Wed Jul 2 08:57:23 2025 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Investigating tumour epithelial, immune and stroma spatial transcriptomics of poor prognosis BRAF V600E mutated colorectal cancer
    Beatson Cancer Charity
    2025 - 2026
     
  • Investigating BRAF driven systemic neutrophilia and clinical utility of neutrophil blockade in colorectal cancer
    Office of the Chief Scientific Adviser
    2024 - 2026